鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/30 | 2,798 | 2,836 | 2,766 | 2,778 | -3 | -0.1% | 35,500 |
2021/11/29 | 2,855 | 2,855 | 2,767 | 2,781 | -78 | -2.7% | 33,900 |
2021/11/26 | 2,906 | 2,906 | 2,839 | 2,859 | -70 | -2.4% | 26,200 |
2021/11/25 | 2,907 | 2,941 | 2,907 | 2,929 | +25 | +0.9% | 18,300 |
2021/11/24 | 2,936 | 2,945 | 2,894 | 2,904 | -32 | -1.1% | 17,100 |
2021/11/22 | 2,926 | 2,940 | 2,911 | 2,936 | +23 | +0.8% | 16,400 |
2021/11/19 | 2,959 | 2,959 | 2,889 | 2,913 | -39 | -1.3% | 28,600 |
2021/11/18 | 2,965 | 2,965 | 2,942 | 2,952 | -2 | -0.1% | 19,500 |
2021/11/17 | 2,995 | 2,995 | 2,949 | 2,954 | -17 | -0.6% | 15,500 |
2021/11/16 | 3,000 | 3,000 | 2,963 | 2,971 | -20 | -0.7% | 13,200 |
2021/11/15 | 2,992 | 3,000 | 2,979 | 2,991 | +1 | ±0% | 21,600 |
2021/11/12 | 2,956 | 2,998 | 2,942 | 2,990 | +43 | +1.5% | 36,200 |
2021/11/11 | 2,970 | 2,974 | 2,939 | 2,947 | -27 | -0.9% | 24,800 |
2021/11/10 | 2,965 | 2,979 | 2,955 | 2,974 | +19 | +0.6% | 25,500 |
2021/11/09 | 2,959 | 2,972 | 2,939 | 2,955 | +14 | +0.5% | 31,000 |
2021/11/08 | 2,924 | 2,969 | 2,919 | 2,941 | +23 | +0.8% | 44,200 |
2021/11/05 | 2,910 | 2,924 | 2,833 | 2,918 | -20 | -0.7% | 75,000 |
2021/11/04 | 2,960 | 2,985 | 2,925 | 2,938 | -12 | -0.4% | 63,800 |
2021/11/02 | 2,980 | 2,995 | 2,935 | 2,950 | -20 | -0.7% | 50,500 |
2021/11/01 | 3,000 | 3,000 | 2,930 | 2,970 | +20 | +0.7% | 46,000 |
2021/10/29 | 2,950 | 2,980 | 2,936 | 2,950 | +17 | +0.6% | 35,000 |
2021/10/28 | 2,943 | 2,973 | 2,933 | 2,933 | -10 | -0.3% | 55,600 |
2021/10/27 | 2,952 | 2,977 | 2,943 | 2,943 | -9 | -0.3% | 29,200 |
2021/10/26 | 2,926 | 2,964 | 2,922 | 2,952 | +26 | +0.9% | 64,900 |
2021/10/25 | 2,920 | 2,948 | 2,900 | 2,926 | -21 | -0.7% | 40,900 |
2021/10/22 | 2,932 | 2,963 | 2,926 | 2,947 | -5 | -0.2% | 43,200 |
2021/10/21 | 2,936 | 2,955 | 2,932 | 2,952 | +5 | +0.2% | 22,000 |
2021/10/20 | 2,950 | 2,968 | 2,943 | 2,947 | -14 | -0.5% | 28,700 |
2021/10/19 | 2,931 | 2,980 | 2,931 | 2,961 | +11 | +0.4% | 38,200 |
2021/10/18 | 3,035 | 3,035 | 2,946 | 2,950 | -85 | -2.8% | 40,600 |
2021/10/15 | 2,991 | 3,050 | 2,985 | 3,035 | +44 | +1.5% | 21,800 |
2021/10/14 | 2,952 | 3,005 | 2,950 | 2,991 | +35 | +1.2% | 35,800 |
2021/10/13 | 2,971 | 2,972 | 2,950 | 2,956 | -5 | -0.2% | 15,900 |
2021/10/12 | 2,971 | 2,979 | 2,946 | 2,961 | -31 | -1% | 40,700 |
2021/10/11 | 2,956 | 2,992 | 2,947 | 2,992 | +32 | +1.1% | 14,100 |
2021/10/08 | 2,985 | 2,990 | 2,952 | 2,960 | +9 | +0.3% | 25,900 |
2021/10/07 | 2,992 | 2,992 | 2,930 | 2,951 | -42 | -1.4% | 37,200 |
2021/10/06 | 2,927 | 2,999 | 2,921 | 2,993 | +111 | +3.9% | 54,400 |
2021/10/05 | 2,910 | 2,917 | 2,870 | 2,882 | -61 | -2.1% | 57,200 |
2021/10/04 | 2,901 | 2,943 | 2,901 | 2,943 | +37 | +1.3% | 34,100 |
2021/10/01 | 2,925 | 2,933 | 2,895 | 2,906 | -39 | -1.3% | 45,200 |
2021/09/30 | 2,920 | 2,969 | 2,914 | 2,945 | +10 | +0.3% | 53,400 |
2021/09/29 | 2,979 | 2,979 | 2,931 | 2,935 | -55 | -1.8% | 84,600 |
2021/09/28 | 3,015 | 3,015 | 2,963 | 2,990 | -30 | -1% | 68,100 |
2021/09/27 | 3,055 | 3,055 | 3,005 | 3,020 | -35 | -1.1% | 36,700 |
2021/09/24 | 3,075 | 3,080 | 3,025 | 3,055 | +35 | +1.2% | 36,100 |
2021/09/22 | 3,030 | 3,060 | 3,010 | 3,020 | -30 | -1% | 34,900 |
2021/09/21 | 3,030 | 3,070 | 2,985 | 3,050 | -30 | -1% | 37,400 |
2021/09/17 | 3,035 | 3,095 | 3,020 | 3,080 | +45 | +1.5% | 47,600 |
2021/09/16 | 3,010 | 3,035 | 3,000 | 3,035 | ±0 | ±0% | 54,700 |
851~
900
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム